These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 1944424

  • 1. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC, Hasler WL, Owyang C.
    N Engl J Med; 1991 Nov 21; 325(21):1461-7. PubMed ID: 1944424
    [Abstract] [Full Text] [Related]

  • 2. Interdigestive motor activity in patients with systemic sclerosis.
    Rees WD, Leigh RJ, Christofides ND, Bloom SR, Turnberg LA.
    Gastroenterology; 1982 Sep 21; 83(3):575-80. PubMed ID: 6124475
    [Abstract] [Full Text] [Related]

  • 3. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
    Fiorucci S, Distrutti E, Gerli R, Morelli A.
    Am J Gastroenterol; 1994 Apr 21; 89(4):550-5. PubMed ID: 8147358
    [Abstract] [Full Text] [Related]

  • 4. Octreotide in gastrointestinal motility disorders.
    Owyang C.
    Gut; 1994 Apr 21; 35(3 Suppl):S11-4. PubMed ID: 8206395
    [Abstract] [Full Text] [Related]

  • 5. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS, Chen GH, Lien HC, Yeh HZ.
    Hepatology; 1998 Nov 21; 28(5):1187-90. PubMed ID: 9794900
    [Abstract] [Full Text] [Related]

  • 6. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V, Duval X, Crickx B, Bouscarat F, Coffin B, Belaich S.
    Eur J Dermatol; 1999 Sep 21; 9(6):446-8. PubMed ID: 10491499
    [Abstract] [Full Text] [Related]

  • 7. [Value of intestinal manometry in gastrointestinal pathology].
    Madrid AM, Quera R, Defilippi C.
    Rev Med Chil; 1999 Oct 21; 127(10):1176-82. PubMed ID: 10835733
    [Abstract] [Full Text] [Related]

  • 8. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J.
    Am J Gastroenterol; 1997 Dec 21; 92(12):2250-6. PubMed ID: 9399764
    [Abstract] [Full Text] [Related]

  • 9. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I, Ducrotté P, Denis P, Menard JF, Levesque H.
    Rheumatology (Oxford); 2009 Oct 21; 48(10):1314-9. PubMed ID: 19696066
    [Abstract] [Full Text] [Related]

  • 10. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.
    Vantrappen G, Janssens J, Hellemans J, Ghoos Y.
    J Clin Invest; 1977 Jun 21; 59(6):1158-66. PubMed ID: 864008
    [Abstract] [Full Text] [Related]

  • 11. Small intestinal manometry in patients with systemic sclerosis.
    Sjölund K, Bartosik I, Lindberg G, Scheja A, Wildt M, Akesson A.
    Eur J Gastroenterol Hepatol; 2005 Nov 21; 17(11):1205-12. PubMed ID: 16215433
    [Abstract] [Full Text] [Related]

  • 12. Further classification of dysmotility-like dyspepsia by interdigestive gastroduodenal manometry and plasma motilin level.
    Kusano M, Sekiguchi T, Kawamura O, Kikuchi K, Miyazaki M, Tsunoda T, Horikoshi T, Mori M.
    Am J Gastroenterol; 1997 Mar 21; 92(3):481-4. PubMed ID: 9068474
    [Abstract] [Full Text] [Related]

  • 13. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients.
    Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP.
    J Clin Rheumatol; 2007 Jun 21; 13(3):119-23. PubMed ID: 17551375
    [Abstract] [Full Text] [Related]

  • 14. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M, Chow EJ, Lin HC.
    Am J Gastroenterol; 2000 Dec 21; 95(12):3503-6. PubMed ID: 11151884
    [Abstract] [Full Text] [Related]

  • 15. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C, Läritz M, Meurer M, Endres SP, König A, Schindlbeck N.
    Z Gastroenterol; 1997 Oct 21; 35(10):905-12. PubMed ID: 9432812
    [Abstract] [Full Text] [Related]

  • 16. [Endogenous ethanol production in patients with liver cirrhosis, motor alteration and bacterial overgrowth].
    Madrid AM, Hurtado C, Gatica S, Chacón I, Toyos A, Defilippi C.
    Rev Med Chil; 2002 Dec 21; 130(12):1329-34. PubMed ID: 12611233
    [Abstract] [Full Text] [Related]

  • 17. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up.
    Marie I, Ducrotté P, Denis P, Hellot MF, Levesque H.
    Rheumatology (Oxford); 2007 Jan 21; 46(1):150-3. PubMed ID: 16782730
    [Abstract] [Full Text] [Related]

  • 18. Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs.
    Nakada K, Ikoma A, Suzuki T, Reynolds JC, Campbell WL, Todo S, Starzl TE.
    Am J Surg; 1995 Mar 21; 169(3):294-9. PubMed ID: 7879829
    [Abstract] [Full Text] [Related]

  • 19. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C.
    Am J Gastroenterol; 2001 Apr 21; 96(4):1251-5. PubMed ID: 11316178
    [Abstract] [Full Text] [Related]

  • 20. [Hydrogen (H2) breath tests in the diagnosis of small intestine diseases].
    Wildgrube HJ, Classen M.
    Z Gastroenterol; 1983 Nov 21; 21(11):628-36. PubMed ID: 6659630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.